Apricus Wealth, LLC Amgen Inc Transaction History

Apricus Wealth, LLC

$150 Million
Q3 2024

A detailed history of Apricus Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Apricus Wealth, LLC holds 12,292 shares of AMGN stock, worth $3.27 Million. This represents 2.65% of its overall portfolio holdings.

Number of Shares

12,292

Previous 12,777 3.8%

Holding current value

$3.27 Million

Previous $3.99 Million 0.8%

% of portfolio

2.65%

Previous 2.9%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $150,049 - $163,629	-485 Reduced 3.8%	12,292 $3.96 Million
Q2 2024 Jul 25, 2024	SELL	$262.75 - $319.31 $192,858 - $234,373	-734 Reduced 5.43%	12,777 $3.99 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $20,165 - $24,342	-75 Reduced 0.55%	13,511 $3.84 Million
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $77,221 - $87,114	-302 Reduced 2.17%	13,586 $3.91 Million
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $41,543 - $51,577	-190 Reduced 1.35%	13,888 $3.73 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $58,924 - $69,676	275 Added 1.99%	14,078 $3.13 Million
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $120,120 - $146,406	532 Added 4.01%	13,803 $3.34 Million
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $4,351 - $5,529	19 Added 0.14%	13,271 $3.49 Million
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $52,748 - $59,490	-235 Reduced 1.74%	13,252 $2.99 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $30,223 - $33,632	131 Added 0.98%	13,487 $3.28 Million
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $273,648 - $302,727	1,248 Added 10.31%	13,356 $3.41 Million
Q4 2021 Mar 09, 2022	BUY	$198.88 - $227.6 $2.41 Million - $2.76 Million	12,108 New	12,108 $2.72 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apricus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apricus Wealth, LLC with notifications on news.

Account

Apricus Wealth, LLC Amgen Inc Transaction History